Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone86-53-5685-7928
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Bohai Pharmaceuticals Group (OTCMKTS:BOPH) Frequently Asked Questions
What is Bohai Pharmaceuticals Group's stock symbol?
Bohai Pharmaceuticals Group trades on the OTCMKTS under the ticker symbol "BOPH."
Has Bohai Pharmaceuticals Group been receiving favorable news coverage?
Media headlines about BOPH stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Bohai Pharmaceuticals Group earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Bohai Pharmaceuticals Group.
Who are some of Bohai Pharmaceuticals Group's key competitors?
Some companies that are related to Bohai Pharmaceuticals Group include Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), Capstone Therapeutics (CAPS), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), Forward Pharma A/S (FWP), FutureWorld (FWDG), GlobeImmune (GBIM), Immune Therapeutics (IMUN), Mereo BioPharma Group (MREO), Myrexis (MYRX) and NeuroVive Pharmaceutical (NEVPF).
Who are Bohai Pharmaceuticals Group's key executives?
Bohai Pharmaceuticals Group's management team includes the folowing people:
- Mr. Hongwei Qu, Founder, Chairman, CEO, Pres, Principal Financial Officer and GM (Age 43)
- Ms. Chunhong Jiang, Sec. and Treasurer (Age 53)
How do I buy shares of Bohai Pharmaceuticals Group?
Shares of BOPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Bohai Pharmaceuticals Group's stock price today?
One share of BOPH stock can currently be purchased for approximately $0.00.
What is Bohai Pharmaceuticals Group's official website?
How can I contact Bohai Pharmaceuticals Group?
Bohai Pharmaceuticals Group's mailing address is C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD ZHIFU DISTRICT, YANTAI F4, 264000. The company can be reached via phone at 86-53-5685-7928 or via email at [email protected]
MarketBeat Community Rating for Bohai Pharmaceuticals Group (OTCMKTS BOPH)
MarketBeat's community ratings are surveys of what our community members think about Bohai Pharmaceuticals Group and other stocks. Vote "Outperform" if you believe BOPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
